Report

global biosimilars market trends 2014 2020

Global Biosimilars Market Report 2014-2020

pages Pages:
tables Tables:
charts Charts:
country Regions/Countries:
compaines Companies:
enqhours Enquiry Hours:
  • Get Free 10% Customization in this Report
Biosimilars are medical products, which have undergone patent expiration originally produced by another company. These products can be manufactured when the original products’ patent expires. The market is mainly driven by biosimilars applications related to chronic diseases, whose patent rules have changed. The Global Biosimilars market is expected to grow at a rapid pace during the forecast period due to the emergence of off-patent biologic products. The recombinant non-glycosylated proteins segment is expected to drive the Biosimilars market due to increase in the number of diabetes patients and new versions of insulins.

Europe is expected to have the highest market share because of the arrival of new innovations and patent expiry of biosimilars products in this region. Europe is followed by the APAC region, whose growth is driven by the use of biosimilars products and cost effective treatment for chronic diseases. The North American market is driven by collaborations among key manufacturers. Some of the major players in the market include Amgen Inc., Biocon Ltd., Celltrion Inc., and others.

Infoholic Research’s Global Biosimilars Market report provides detailed information about various market trends and applications covering different segments and regions. The major trends, drivers, restraints and opportunities in each segment are also covered. This study will help stakeholders to understand the current and future market outlook to focus/expand/invest in the Global Biosimilars market.

This report also provides the competitive landscape of the leading players in Global Biosimilars market and this study will help the vendors to understand about their competitor’s landscape. The report can also be tailored as per the specific user requirement. The customization of the report is available based on countries, vendor profiles, enterprise, and vertical wise.
1     Industry Outlook 

1.1        Industry Overview

1.2        Industry Trends

1.3        Pest Analysis

2     Report Outline 

2.1        Report Scope

2.2        Report Summary

2.3        Research Methodology

2.4        Report Assumptions

3     Market Snapshot

3.1        Total Addressable Market (TAM)

3.2        Segmented Addressable Market (SAM)

3.3        Related Markets

4     Market Outlook 

4.1        Overview

4.2        Market Definition – Infoholic Research

4.3        Evolution

4.4        Market Trends

4.5        Importance of Biosimilars Market

4.6        Market Segmentation

4.7        Porter 5(Five) Forces

5     Market Characteristics

5.1        Biosimilars Features

5.2        Biosimilars Advantages

5.3        Biosimilars Scope

5.4        Market Dynamics

5.4.1     Drivers

5.4.2     Opportunities

5.4.3     Restraints

5.4.4     DRO – Impact Analysis

5.4.5     Key Stakeholders

6     Product: Market Size and Analysis

6.1        Overview

6.2        Recombinant Non-glycosylated Proteins

6.3        Peptides

6.4        Others

7     Manufacturing: Market Size and Analysis

7.1        Overview

7.2        In-House

7.3        CMO

8     Application: Market Size and Analysis

8.1        Overview

8.2        Blood Disorders

8.3        Oncology

9     Regions: Market Size and Analysis

9.1        Overview

9.2        Americas

9.3        EMEA

9.4        APAC

10   Market Attractiveness

10.1     Market Attractiveness by Product

10.2     Market Attractiveness by Manufacturing

10.2     Market Attractiveness by Application

10.3     Market Attractiveness by Regions

11   Competitive Landscape 

11.1     Overview

11.2     Vendor Assessment

12   Vendor Profiles

13   Companies to Watch For

14   Global Generalist

Annexure 

Abbreviations

 

Research Framework

Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting
Methodology

Market related information is congregated from both primary and secondary sources.

Primary sources

Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

outicon

Global Biosimilars Market Report 2014-2020
Interested in this report?
Get your FREE sample now!

Select User License

$

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase

Speak to our analyst
Related Reports